|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | Alcon Research |
|---|---|
| Information provided by: | Alcon Research |
| ClinicalTrials.gov Identifier: | NCT00532415 |
Purpose
Vitreous delineating agents are used in ophthalmic surgery to permit visualization of structures in the back of the eye to aid in their removal and improve safety of the surgery.
If you agree to participate in the study, your surgeon will inject the vitreous delineating agent inside your eye at some point during your surgery. When your surgeon no longer needs a visualization aid, the vitreous delineating agent will be removed from the inside of your eye as much as possible. If you decide to participate, this clinical study will last approximately one week.
| Condition | Intervention | Phase |
|---|---|---|
|
Vitrectomy |
Procedure: Vitrectomy using triamcinolone acetonide |
Phase III |
| Study Type: | Interventional |
| Study Design: | Treatment, Non-Randomized, Single Blind, Uncontrolled, Single Group Assignment, Safety/Efficacy Study |
| Official Title: | Clinical Evaluation of the Safety and Efficacy of Vitreous Delineating Agent for Visualization During Vitrectomy Surgery |
| Estimated Enrollment: | 60 |
| Study Start Date: | September 2007 |
| Primary Completion Date: | September 2007 (Final data collection date for primary outcome measure) |
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Study ID Numbers: | C-05-62 |
| Study First Received: | September 19, 2007 |
| Last Updated: | July 25, 2008 |
| ClinicalTrials.gov Identifier: | NCT00532415 History of Changes |
| Health Authority: | United States: Food and Drug Administration |
|
Vitrectomy Visualization |
|
Anti-Inflammatory Agents Molecular Mechanisms of Pharmacological Action Immunologic Factors Physiological Effects of Drugs Hormones, Hormone Substitutes, and Hormone Antagonists Enzyme Inhibitors Triamcinolone diacetate Glucocorticoids |
Hormones Immunosuppressive Agents Pharmacologic Actions Triamcinolone hexacetonide Triamcinolone Acetonide Therapeutic Uses Triamcinolone |